JOSEPH ALI: Open Payments
NPI 1417238403 · WAPPINGERS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,540 in 85 payments from 12 companies in 2025. Trend: 2023 $1,455 · 2024 $808 · 2025 $1,540
Food & beverage: $1,540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $583 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $177 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Lundbeck LLC | 4 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Alkermes, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
Products named: VRAYLAR, CAPLYTA, TRINTELLIX, REXULTI, Auvelity, AUSTEDO XR, COBENFY, LYBALVI.
Industry payments across NY — which companies pay providers there.
